Currently predicting for Mon, 1 Apr 2024

CYAD Predictions History

4 years ago
JS predicted that CYAD for 2020-02-18 is going $10.32 (-4.80%)

4 years ago
Tonia Allen Gould predicted that CYAD for 2020-02-18 is going

Rank:

4 years ago
JS predicted that CYAD for 2019-07-01 is going $11.25 (-1.92%)

Click to get the best stock tips daily for free!

About Celyad SA

Celyad SA Celyad Oncology SA, a clinical-stage biopharmaceutical company, focuses on the discovery and development of chimeric antigen receptor T (CAR-T) cell therapies for the treatment of cancer. Its lead product candidates include CYAD-101, an allogeneic CAR-T candidate that is in Phase 1b clinical trial for the treatment of metastatic colorectal cancer; CYAD-211, a short hairpin RNA (shRNA)-based allogeneic CAR-T candidate, which is in Phase 1 clinical... CYAD Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT